Abstract
Quality by Design (QbD) and Process Analytical Technology (PAT) initiatives proposed by Food and Drug Administration (USFDA), since 2002, have stimulated pharmaceutical industry worldwide to develop process with high level of scientific understanding of the relationship between operation parameters and product and process critical quality attributes, from early stages of technological dev…